ctrl K

Watchlist Price Alert

Taysha Gene Therapies Inc... (TSHA)

NASDAQ: TSHA · Real-Time Price · USD

2.60

0.04 (1.56%)

At close: Jun 17, 2025, 2:05 PM

Taysha Gene Therapies Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	139.04M	143.94M	87.88M	149.1M	251.25M	n/a
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	2.64M	2.64M	n/a	n/a
Other Long-Term Assets	2.37M	2.46M	3.95M	1.11M	7.34M	15K
Receivables	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	892K	4.83M	6.03M	6.63M	2.79M	15K
Total Current Assets	142.13M	149.87M	96.42M	159.6M	251.25M	15K
Property-Plant & Equipment	15.87M	20.41M	25.91M	50.61M	287K	n/a
Goodwill & Intangibles	n/a	n/a	-4.99M	n/a	n/a	n/a
Total Long-Term Assets	18.23M	22.86M	29.86M	54.35M	7.63M	15K
Total Assets	160.36M	172.73M	126.28M	213.96M	258.88M	15K
Account Payables	3.59M	6.37M	10.95M	21.76M	1.99M	n/a
Deferred Revenue	9.77M	18.11M	33.56M	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	6.43M	7.21M	14.25M	4.13M	264K	21K
Total Current Liabilities	26.23M	36.76M	62.79M	51.75M	7.13M	150K
Long-Term Debt	43.94M	40.51M	37.97M	37.19M	n/a	n/a
Other Long-Term Liabilities	1.31M	1.58M	4.13M	3.73M	450K	n/a
Total Long-Term Liabilities	62.61M	61.04M	62.54M	66.83M	450K	n/a
Total Liabilities	88.84M	97.79M	125.33M	118.57M	7.58M	150K
Total Debt	63.18M	61.11M	59.93M	63.09M	n/a	n/a
Common Stock	2K	2K	1K	n/a	n/a	n/a
Retained Earnings	-602.3M	-513.01M	-401.44M	-235.65M	-61.13M	-1.11M
Comprehensive Income	-4.03M	-0.00	-0.00	n/a	-0.00	n/a
Shareholders Equity	71.53M	74.94M	949K	95.38M	251.3M	-135K
Total Investments	n/a	2.15M	2.64M	2.64M	n/a	n/a